Company news
InMed Pharmaceuticals Inc. news in 2020
InMed Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.
InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
December 2, 2020
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
November 24, 2020
InMed Announces Election of Directors
November 23, 2020
InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics
November 17, 2020
InMed Pharmaceuticals Announces the Closing of US$8 Million Public Offering
November 15, 2020
InMed Pharmaceuticals Reports First Quarter Fiscal 2021 IFRS Financial Results
November 12, 2020
InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM"
November 11, 2020